<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00750646</url>
  </required_header>
  <id_info>
    <org_study_id>SI-08-54</org_study_id>
    <nct_id>NCT00750646</nct_id>
  </id_info>
  <brief_title>Observational Study of How Patients Take Eye Drops</brief_title>
  <official_title>The Relationship Between Glaucoma Medication Self-Efficacy, Outcome Expectations, Eye Drop Tech., Adherence and IOP.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Robin, Alan L., M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Robin, Alan L., M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is interested in monitoring how patients take eye drops, both through
      video-recordings and adherence monitoring, as well as their perceptions about their eye
      medications; including the dosing schedules, instillation techniques and effect on their
      disease.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">August 2009</completion_date>
  <primary_completion_date type="Anticipated">March 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Medication adherence measured by MEMS caps</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Eye drop technique measured by video evaluation</measure>
    <time_frame>1 time observation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medication adherence measured by self-report</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of VF damage</measure>
    <time_frame>1 test date</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular pressure readings</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <description>Subject's adherence to prescribed therapy will be monitored with an electronic compliance device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MEMS cap</intervention_name>
    <description>The Medication Event Monitoring System will be used to assess the level of subject adherence to recommended topical eye drop therapy.</description>
    <arm_group_label>A</arm_group_label>
    <other_name>MEMS</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be enrolled for a single site, private practice.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 year old

          -  currently taking 1 or more hypotensive topical eye drops takes drops in the right eye
             for more than 6 months expect to continue drop use for the next 3 months

          -  subjects instill their own eye drops

          -  subject is able to take HVF tests

          -  subject will expect to complete the 3 months enrollment period

        Exclusion Criteria:

          -  unable/unwilling to instill own medications

          -  eye drops are discontinued

          -  unable to take HVF test

          -  unable to complete follow-up

          -  investigators discontinue subject for safety reasons

          -  not using drops in left eye
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer L Stone, OD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glaucoma Experts</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alan L Robin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glaucoma Specialists</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Colleen K Protzko</last_name>
    <role>Study Director</role>
    <affiliation>Glaucoma Specialists</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer L Stone, OD</last_name>
    <phone>410 377 2422</phone>
    <email>jstone@glacuomaexpert.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Colleen K Protzko</last_name>
    <phone>4103772422</phone>
    <email>cprotzko@glaucomaexpert.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Glaucoma Specialists</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen K Protzko</last_name>
      <phone>410-377-2422</phone>
      <email>cprotzko@glaucomaexpert.com</email>
    </contact>
    <contact_backup>
      <last_name>Millie Brummett</last_name>
      <phone>4103772422</phone>
    </contact_backup>
    <investigator>
      <last_name>Jennifer L Stone, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alan L Robin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2008</study_first_submitted>
  <study_first_submitted_qc>September 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2008</study_first_posted>
  <last_update_submitted>September 9, 2008</last_update_submitted>
  <last_update_submitted_qc>September 9, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2008</last_update_posted>
  <responsible_party>
    <name_title>Alan L. Robin</name_title>
    <organization>Glaucoma Specialists</organization>
  </responsible_party>
  <keyword>compliance</keyword>
  <keyword>eye drop administration</keyword>
  <keyword>MEMS</keyword>
  <keyword>adherence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

